A comparison of menotropin, highly-purified menotropin and follitropin alfa in cycles of intracytoplasmic sperm injection

Table 8 Total gonadotropin dose requirement to achieve clinical pregnancy/live birth in the 865 ICSI cycles.

	hMG	HP-hMG	r-hFSH	p value
Cycles with clinical pregnancy, IU	2519 (± 684)^a	2655 (± 612)^b	2237 (± 582)^c	0.002 (^{a, b} vs ^c)
Cycles with live birth, IU	2515 (± 613)^a	2651 (± 614)^b	2243 (± 589)^c	0.02 (^{a, b} vs ^c)

Total dose of menotropin (hMG), highly-purified menotropin (HP-hMG) and follitropin alfa (r-hFSH) used per cycle resulting in a clinical pregnancy (n = 320) and per cycle resulting in a live birth (n = 251) (mean [± SD]).
hMG, human menopausal gonadotropin; HP-hMG, highly purified hMG; ICSI, intracytoplasmic sperm injection; r-hFSH, recombinant human follicle-stimulating hormone; SD, standard deviation.

ISSN: 1477-7827